Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
about
DNA damage predicts prognosis and treatment response in colorectal liver metastases superior to immunogenic cell death and T cells.Phase Ib/II trial evaluating the safety, tolerability and immunological activity of durvalumab (MEDI4736) (anti-PD-L1) plus tremelimumab (anti-CTLA-4) combined with FOLFOX in patients with metastatic colorectal cancer.Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy).
P2860
Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Comprehensive Intrametastatic ...... ct of Immunoscore on Survival.
@en
Comprehensive Intrametastatic ...... ct of Immunoscore on Survival.
@nl
type
label
Comprehensive Intrametastatic ...... ct of Immunoscore on Survival.
@en
Comprehensive Intrametastatic ...... ct of Immunoscore on Survival.
@nl
prefLabel
Comprehensive Intrametastatic ...... ct of Immunoscore on Survival.
@en
Comprehensive Intrametastatic ...... ct of Immunoscore on Survival.
@nl
P2093
P2860
P356
P1476
Comprehensive Intrametastatic ...... ct of Immunoscore on Survival.
@en
P2093
Anne Berger
Anne Jouret-Mourin
Bernhard Mlecnik
Catherine Hubert
Cristina Dragean
Daphné Debetancourt
Etienne Danse
Florence Marliot
Franck Pagès
Gabriela Bindea
P2860
P356
10.1093/JNCI/DJX123
P407
P577
2018-01-01T00:00:00Z